Since NEU hasn't given up on TBI and concussion, I'm wondering...

Since NEU hasn't given up on TBI and concussion, I'm wondering how that is playing out in the current negotiations? Along with NNZ-2591, there would appear to be a complexity that would explain the length of time this is all taking.

Given the potential of everything other than the treatment for Rett Syndrome, it is almost beyond comprehension as to how that might be valued.

Then there is the prospect of trofinetide being approved for Rett Syndrome and subsequently being prescribed for other parts of the autism spectrum - how is that controlled by NEU in their best interests?